NASDAQ: KLRA
Kailera Therapeutics Inc Stock Ownership - Who owns Kailera Therapeutics?

Insider buying vs selling

Have Kailera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bain Capital Investors LLC10% Owner2026-04-208,398,438$16.00
$134.38MBuy
Bain Capital Life Sciences Investors LLC10% Owner2026-04-201,562,500$16.00
$25.00MBuy
Andrew T. KaplanDirector2026-04-208,398,438$16.00
$134.38MBuy
Adam KoppelDirector2026-04-201,562,500$16.00
$25.00MBuy
Rtw Investments LP10% Owner2026-04-20500,000$16.00
$8.00MBuy

1 of 1

KLRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KLRA insiders and whales buy or sell their stock.

KLRA Shareholders

What type of owners hold Kailera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew T. Kaplan20.26%26,255,581$508.57MInsider
Bain Capital Investors LLC20.26%26,255,581$508.57MInsider
Bain Capital Life Sciences Investors LLC17.43%22,583,268$437.44MInsider
Adam Koppel17.43%22,583,268$437.44MInsider
Rtw Investments LP8.32%10,776,820$208.75MInsider
Jiangsu Hengrui Pharmaceuticals Co Ltd1.57%2,034,134$39.40MInsider

1 of 1

KLRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLRA0.00%85.28%Net BuyingNet Buying
IDYA92.57%7.43%Net Buying
TARS73.42%26.58%Net SellingNet Selling
IRON62.62%37.38%Net SellingNet Selling
DFTX63.45%36.55%Net SellingNet Selling

Kailera Therapeutics Stock Ownership FAQ

Who owns Kailera Therapeutics?

Kailera Therapeutics (NASDAQ: KLRA) is owned by 0.00% institutional shareholders, 85.28% Kailera Therapeutics insiders, and 14.72% retail investors. Andrew T. Kaplan is the largest individual Kailera Therapeutics shareholder, owning 26.26M shares representing 20.26% of the company. Andrew T. Kaplan's Kailera Therapeutics shares are currently valued at $508.57M.

If you're new to stock investing, here's how to buy Kailera Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.